Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds
Background N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a cardiac biomarker whose plasma concentration is high in some dogs with cardiopulmonary disease. NT‐proBNP is a diagnostic tool that can be used to help determine if a patient has congestive heart failure. Greyhounds have functiona...
Saved in:
Published in | Veterinary clinical pathology Vol. 44; no. 3; pp. 405 - 409 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.09.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a cardiac biomarker whose plasma concentration is high in some dogs with cardiopulmonary disease. NT‐proBNP is a diagnostic tool that can be used to help determine if a patient has congestive heart failure. Greyhounds have functional heart murmurs, relative cardiomegaly, and high serum cTnI concentration.
Objectives
The purpose of the study was to evaluate the plasma concentration of NT‐proBNP in healthy Greyhounds and compare it to non‐Greyhound dogs.
Methods
We prospectively evaluated healthy client‐owned dogs including retired racing Greyhounds and non‐Greyhounds. Plasma was obtained and transferred into tubes containing a protease inhibitor and submitted for a specific NT‐proBNP ELISA assay.
Results
The plasma NT‐proBNP concentration in Greyhounds was significantly higher than in non‐Greyhound control dogs (946 vs 632 pmol/L; P < .005); 46% of Greyhounds had NT‐proBNP > 1000 pmol/L.
Conclusions
Plasma NT‐proBNP concentration in Greyhounds is high and should be interpreted with caution. |
---|---|
Bibliography: | ArticleID:VCP12266 ark:/67375/WNG-FPPVTHRL-G istex:F0F6CD639951EC60C8C3442485132DB5FE6596D7 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0275-6382 1939-165X |
DOI: | 10.1111/vcp.12266 |